Banque Pictet & Cie SA lessened its position in Oracle Corporation (NYSE:ORCL - Free Report) by 15.6% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 11,360 shares of the enterprise software provider's stock after selling 2,100 shares during the period. Banque Pictet & Cie SA's holdings in Oracle were worth $2,484,000 at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in ORCL. Brighton Jones LLC lifted its stake in shares of Oracle by 189.3% in the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider's stock valued at $25,593,000 after purchasing an additional 100,494 shares during the period. Revolve Wealth Partners LLC lifted its stake in shares of Oracle by 8.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider's stock valued at $903,000 after purchasing an additional 404 shares during the period. Mascagni Wealth Management Inc. acquired a new stake in shares of Oracle in the fourth quarter valued at about $77,000. Wellington Management Group LLP lifted its stake in shares of Oracle by 200.4% in the fourth quarter. Wellington Management Group LLP now owns 172,483 shares of the enterprise software provider's stock valued at $28,743,000 after purchasing an additional 115,059 shares during the period. Finally, MassMutual Private Wealth & Trust FSB lifted its stake in shares of Oracle by 11.0% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 17,006 shares of the enterprise software provider's stock valued at $2,378,000 after purchasing an additional 1,687 shares during the period. Institutional investors and hedge funds own 42.44% of the company's stock.
Insiders Place Their Bets
In other news, Director William G. Parrett sold 11,500 shares of the business's stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the completion of the transaction, the director owned 17,764 shares of the company's stock, valued at $5,435,784. The trade was a 39.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Clayton M. Magouyrk sold 21,241 shares of the business's stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the completion of the sale, the insider owned 78,000 shares of the company's stock, valued at approximately $23,174,580. The trade was a 21.40% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 112,092 shares of company stock valued at $32,960,165. 42.20% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several analysts recently commented on the stock. Bank of America upgraded shares of Oracle from a "neutral" rating to a "buy" rating and raised their price objective for the company from $295.00 to $368.00 in a research note on Wednesday, September 10th. Oppenheimer reiterated an "outperform" rating on shares of Oracle in a research note on Wednesday, June 18th. Berenberg Bank raised their price objective on shares of Oracle from $202.00 to $306.00 and gave the company a "hold" rating in a research note on Monday, September 15th. Rothschild Redb upgraded shares of Oracle to a "strong sell" rating in a research report on Thursday. Finally, Stifel Nicolaus lifted their target price on shares of Oracle from $250.00 to $350.00 and gave the stock a "buy" rating in a research report on Wednesday, September 10th. Two analysts have rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating, nine have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $304.71.
Check Out Our Latest Stock Report on ORCL
Oracle Stock Performance
NYSE:ORCL opened at $283.29 on Friday. The firm has a 50 day simple moving average of $258.19 and a 200-day simple moving average of $200.44. The company has a debt-to-equity ratio of 3.33, a current ratio of 0.62 and a quick ratio of 0.62. The firm has a market cap of $805.03 billion, a PE ratio of 65.58, a P/E/G ratio of 3.13 and a beta of 1.46. Oracle Corporation has a 1-year low of $118.86 and a 1-year high of $345.72.
Oracle (NYSE:ORCL - Get Free Report) last posted its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts' consensus estimates of $1.48 by ($0.01). The firm had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the prior year, the firm earned $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, equities analysts expect that Oracle Corporation will post 5 EPS for the current year.
Oracle Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle's payout ratio is currently 46.30%.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report